The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 11.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 6% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 22%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (19 analysts) rates it buy, with a mean price target of $16. Insiders have been net sellers over the past quarter.
Venture Global Inc
VG · the NYSE · USD · Market cap $33.1B · 2,000 employees
Venture Global, Inc., a liquefied natural gas (LNG) company, engages in the ownership, development, construction, and operation of LNG production facilities and associated infrastructure in the United States, Germany, Fr…
FAIL · Does not pass the screenPrice as of 19 Nov 2026Daily close, not a live quote
Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price12.13 USD at the 19 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 19 Nov 2026
- Our regime readAccumulation, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans to puts (put/call 2.29)
- Last reviewed19 Nov 2026 (1 day ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $12.60 to $18.06, base estimate $15.71 (screen dated 2026-11-19).
- Trend Accumulation
- Insiders insiders sold, $9,607,706, latest filing 2026-11-18
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 2.29, read 2026-11-18
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its accumulation label.
Venture Global Inc holds its Accumulation at $12.13. The statistical read favours the buyers, held for 234 days.
| Phase | Accumulation |
| Quantitative state | The statistical read favours the buyers, held for 234 days |
| Price at the screen | $12.13 |
| Valuation | 6.35 trailing · 8.28 forward price to earnings |
| Values screen | FAIL · score 70.0 |
Five Screens: VG's Results
FAIL. Debt ratio
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Permissible | Permissible core business | Pass |
| Debt load | 65.30% | Below 33% | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Pass |
| Receivables | 6.12% | Below 49% | Pass |
| Revenue purity | 1.10% | Below 5% | Pass |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadWhy It Falls Short, in Plain English
Venture Global's business is in a permissible area, but its interest-bearing debt is about 65% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when VG's ethical verdict changes
Today VG does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 19 Nov 2026: it trades at roughly a 23% discount to our $15.71 fair value, narrow competitive moat, 42.90% revenue growth.
Model construction and limits: fair-value methodology.
Fair value range in USD, drawn from the 2026-11-19 screen. The gold marker is the market price at the same screen. A 22.8% discount to the base estimate.
Third-party analyst targets: 18 covering, consensus Buy. The average target sits +48% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $15.71, with a range of $12.60 to $18.06, dated to the 2026-11-19 screen.
How our estimate and third-party targets differ.
The Business, in Plain WordsLNG exporter faces cyclical export risks
Think of LNG carriers crisscrossing the Atlantic as the new oil tankers of the 1970s. Venture Global builds the plants that turn US gas into export fuel for Europe and Asia, delivering 59 percent revenue growth, 18 percent profit margins and 26 percent ROE.
Those numbers look attractive on a 13.3 times forward multiple yet the shares already trade above our fair value with only a narrow moat. In a cyclical industry a low multiple often signals peak earnings rather than a bargain, which is why the opportunity rating stays at none despite an ethical pass.
Nineteen analysts still see upside to 16 dollars but the valuation gap and energy cycle exposure keep us on the sidelines. Analysis, not advice.
| Forward P/E | 8.3xcheap for a company growing this fast |
| Trailing P/E | 6.3xvery cheap relative to earnings |
| EPS, trailing | 2.07 |
| EPS, forward | 1.59 |
| Revenue growth | +42.9%growing very fast |
| Profit margin | 31.6%highly profitable on every dollar of sales |
| Return on equity | 46.3%an exceptional return on shareholder capital |
| FCF yield | -28.42% |
| Dividend yield | 0.65% |
| Debt to equity | 3.15heavy leverage: higher risk if revenue softens |
| Current ratio | 0.90below 1: short-term bills exceed liquid assets |
| Short interest, float | 0.68% |
| 52-week range | 5.72 - 17.62 |
| Moat | NARROW |
| Market cap | $33.1B |
| Employees | 2,000 |
VG-specific watchpoints · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Metric definitions and interpretation rules: ticker-page methodology.
Every Entry, As Written
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 2.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 6% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 22%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (19 analysts) rates it buy, with a mean price target of $16. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 6% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 22%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (19 analysts) rates it buy, with a mean price target of $16. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 18% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 22%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (19 analysts) rates it buy, with a mean price target of $16. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 18% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 22%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (19 analysts) rates it buy, with a mean price target of $16. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 4.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 18% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 22%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (19 analysts) rates it buy, with a mean price target of $16. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 7.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 18% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 22%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (19 analysts) rates it buy, with a mean price target of $16. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 12.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 18% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 22%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (19 analysts) rates it buy, with a mean price target of $16. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 18% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 22%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (19 analysts) rates it buy, with a mean price target of $16. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 15.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 18% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 22%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (19 analysts) rates it buy, with a mean price target of $16. Insiders have been net sellers over the past quarter.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- 5 Toxic Energy Stocks to Sell Now That the Blue Wave is Here Yahoo Finance · 6d ago
- LNG Prices Soar. These Exporters Could Benefit as Europe Faces a Tough Winter. Yahoo Finance · 7d ago
- Surging Earnings Estimates Signal Upside for Venture Global (VG) Stock Yahoo Finance · 7d ago
- Wall Street Analysts See a 31.98% Upside in Venture Global (VG): Can the Stock Really Move This High? Yahoo Finance · 7d ago
- New Strong Buy Stocks for November 13th Yahoo Finance · 7d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-18 | Larson Keith D | GC, Secretary | S - Sale+OE | 789,958 | $9,607,706 |
| 2026-11-18 | Thayer Jonathan W | CFO | S - Sale+OE | 222,222 | $2,702,964 |
| 2026-11-12 | Musser Fory | SVP, Development | S - Sale+OE | 500,000 | $6,582,400 |
| 2026-10-19 | Thayer Jonathan W | CFO | S - Sale+OE | 222,222 | $2,819,819 |
| 2026-09-14 | Cothran Brian | COO | S - Sale+OE | 152,660 | $2,465,154 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $12.81 | -6.0% | · | $940 | -6.0% |
| 2 months | $14.02 | -14.1% | · | $859 | -14.1% |
| 3 months | $14.25 | -15.5% | $0.04 | $848 | -15.2% |
| 6 months | $13.77 | -12.6% | $0.06 | $878 | -12.2% |
| 1 year | $7.84 | +53.7% | $0.09 | $1,548 | +54.8% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever VG does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.